A bout 6%-8% of men and 16%-18% of women in the United States and England experience migraines, with or without an aura.
cacious in preventing migraine than sham acupuncture at nonacupuncture points. We also investigated whether the efficacy varied when acupuncture points along different meridians or points along the same meridian were used.
Methods

Study design
We performed a multicentre, single-blind, randomized controlled trial with four arms: three acupuncture groups (Shaoyang-specific, Shaoyang-nonspecific and Yangming-specific acupuncture) and one sham acupuncture (control) group. We followed the guidelines of the International Headache Society for clinical trials involving patients with migraines. 17 Our trial was carried out in nine hospitals in China from April 2008 to December 2009, with a four-week baseline period followed by randomization.
Ethics approval
The trial protocol was approved by all local institutional ethics review boards and follows the principles of the Declaration of Helsinki and the Chinese version of the International Conference on Harmonisation -Good Clinical Practice, including onsite monitoring 18 and training of investigators. 19 All patients gave written informed consent. The trial was registered (clinicaltrials.gov: NCT00599586), and the design has been prepublished. 20 
Setting and participants
Patients were recruited through hospital-based recruitment and television and newspaper advertisements. They had to meet the International Headache Classification's criteria for migraines with or without an aura. 21 We included people who met the following criteria: experienced acute migraine attacks for more than one year with two or more attacks per month during the previous three months and during the baseline period; aged 18-65 years; onset of migraines before age 50; completed a baseline headache diary; did not take any prophylactic migraine medication during the previous month; willing to complete 20 acupuncture treatments during a four-week period (weeks 1-4); and able to provide written informed consent. We excluded patients who had headache due to organic disorders (e.g. subarachnoid hemorrhage, cerebral hemorrhage, cerebral embolism, cerebral thrombosis, vascular malformation, arthritis, hypertension, arteriosclerosis), psychosis, pregnancy or lactation, allergies, bleeding disorders or serious diseases of the heart, liver, kidney or other organs.
Randomization and interventions
Randomization was performed by the National Clinical Trial Center of Chinese Medicine, Chengdu Good Clinical Practice Center. Central randomization was performed by text messages sent by the investigator or by use of a website and email confirmation. The randomization sequence (blocked, stratified for centres) was generated by use of the randomization module of the synthesized management platform of the Chengdu Good Clinical Practice Centre (block length 12, unknown to centres). Patients, outcome assessors and statisticians were blinded as to randomization. Patients were informed that they would receive one of four types of acupuncture treatment, three of which used traditional Chinese acupuncture theories and one which was based on modern acupuncture theory.
The treatments, which included electrostimulation, were provided by specialized acupuncturists who had at least five years' training and five years' experience using a standardized protocol (Table 1) . We selected the acupuncture points according to a systematic review of ancient and modern literature, 16, 22 consensus meetings with experts and experience from our previous study. 23 The Shaoyangspecific and sham acupuncture points chosen were used in a previous study of acute migraine attacks. 23 Acupuncture was applied unilaterally, alternating between the left and right sides. The goal was to elicit a de qi sensation (a range of sensations typically generated by the insertion of a needle into an acupuncture point and the manipulation of the needle) in the three acupuncture groups but not in the sham-acupuncture group. Two types of Hwato needles (Suzhou Hua Tuo Medical Instruments, Suzhuo, China) were used in all groups (length 25-40 mm, diameter 0.25 mm; length 13 mm, diameter 0.18 mm). The patients received 20 treatments (30 min each) over a four-week period: once per day for five consecutive days followed by a two-day break. The details of this procedure have been published. 19 The patients were instructed not to take any regular medications for the treatment of migraines. In cases of severe pain, ibuprofen (300 mg each capsule with sustained release) was allowed as rescue medication.
Outcomes
Our primary outcome was the number of days with a migraine, as recorded by participants in a diary, during a four-week period after acupuncture was given (weeks 5-8 after randomization). Patients were given an explanation of what to classify as a migraine-specific headache. Our secondary outcomes, also obtained from the patients' diaries, were frequency of migraines
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(defined as the number of migraines separated by pain free intervals of at least 48 h), intensity of the migraine on a scale of 0-3, and intensity of pain on a visual analogue scale from 0-10.
Patients completed the diaries during four periods: baseline (4 wks before treatment), treatment (weeks 1-4) and follow-up (weeks 5-8 and 13-16). If a patient took medication for a migraine attack, the patient was asked to document the name, dose and time of intake; they were also asked to record when the pain subsided and any side effects experienced. We measured migraine-specific quality of life using the Migraine-Specific Quality-of-Life Questionnaire 24, 25 at baseline and at weeks 4, 8 and 16. We considered differences in quality of life to be clinically important if there were differences of at least 3.2, 4.6 and 7.5 points between groups for the subscales "role restrictive," "role preventive" and "emotional functional," respectively. 26 We documented any adverse events, dropouts and reasons during the trial period.
Statistical analysis
To have 90% power (5% significance level, twosided) to detect a difference of 1.6 migraine days between the Shaoyang-specific acupuncture and control groups, 105 patients per group were required. 19 We assumed a standard deviation of 2.4 days for the sham acupuncture group and 4.0 days for the Shaoyang-specific group and an improvement of 2.4 and 4.0 days for these two groups. To account for dropouts, we recruited 120 patients per group (480 total).
Before the analyses were performed, a detailed statistical analysis plan was created and signed by the people responsible. The intentionto-treat population was defined as the number of patients assigned to treatment who received at least one treatment session. The per-protocol subgroup was the number of patients who completed the study without major protocol violation. All analyses were based on the intention-totreat population unless otherwise stated.
To account for multiplicity (comparison of three treatment groups with one control group), we used a three-step hierarchical testing procedure for confirmatory analysis of the primary outcome (analysis of covariance adjusted for centre and baseline values) to compare the Shaoyangspecific (step one), Shaoyang-nonspecific (step two) and Yangming-specific (step three) acupunc- ture groups with the control group. If the difference was significant (5% level, two-sided), the subsequent step was performed (otherwise, the subsequent p values were considered explorative).
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For the sensitivity analyses, we analyzed the primary outcome using two types of imputation for missing values for the intention-to-treat population: last observation carried forward and multiple imputation (maximum-likelihood-based regression method). We also analyzed the primary outcome in the per-protocol population.
We analyzed the secondary outcomes by analysis of covariance or Poisson regression adjusted for the centre and baseline value. This analysis was based on the intention-to-treat population. groups (Table 2) . A total of 37 participants were lost at the end of the follow-up period (13 in the Shaoyang-specific acupuncture group, 9 in the Shaoyang-nonspecific acupuncture group, 7 in the Yangming-specific acupuncture group and 8 in the control group). In total, 423 (88.9%) patients received at least 16 acupuncture treatments (108 in the Shaoyang-specific acupuncture group, 102 in the Shaoyang-nonspecific acupuncture group, 106 in the Yangming-specific acupuncture group and 107 in the control group).
Results
Participants
Efficacy
We found no significant differences between any of the three acupuncture groups compared with sham acupuncture (control) for the number of days with a migraine during the four-week period after treatment (weeks 5-8; Table 3 , Figure 2) . We also found no differences between the three acupuncture groups (Shaoyang-specific acupuncture v. Shaoyang-nonspecific acupuncture, p = 0.96; Shaoyang-specific acupuncture v. Yangming-specific acupuncture, p = 0.74; Shaoyang-nonspecific acupuncture v. Yangmingspecific acupuncture, p = 0.71).
The frequency and intensity of migraine attacks during weeks 5-8 were significantly lower in the Shaoyang-specific acupuncture group than in the control group. During weeks 13-16, patients in all three treatment groups reported significantly fewer days with a migraine compared to patients in the control group (Table 3) .
Patients in both Shaoyang acupuncture groups reported better migraine-specific quality of life compared with patients in the control group. Few significant differences were observed between patients in the three acupuncture groups for this outcome (Table 3) .
When we performed the sensitivity analyses after the imputation of missing data and evaluating the per-protocol group, we obtained results similar to those obtained in our main analysis.
Safety
In total, 37 patients (7.8%) experienced 42 adverse events during the study period (9 in the Shaoyang-specific acupuncture group, 8 in the Shaoyang-nonspecific acupuncture group, 12 in the Yangming-specific acupuncture and 8 in the 
Interpretation
We found that acupuncture was more effective than sham acupuncture for almost all secondary outcomes during both study periods (weeks 5-8 and 13-16 after randomization). There was no difference in the number of days with a migraine during the four-week period after treatment. However, we found a clinically minor effect after 16 weeks. We found no relevant differences between the three acupuncture groups. Our secondary findings must be interpreted with caution because of the exploratory test statistics. Our trial had a large sample size, a prevalidated sham control, rigorous experimental methods (including blinding, central randomization, standardization of the intervention, prepublished study protocol, 19 predefined statistical analysis and independent data analyses by two statisticians.
Our results indicate that the style of acupuncture has little relevance on the outcome. Shaoyang-specific acupuncture points did not result in better outcomes than other acupuncture points, suggesting that point-specific effects play a small role in the overall effect. According to our results, nonspecific effects (e.g., expectations and patient-practitioner interaction) may have had a more prominent role and may have been increased by the use of electrostimulation in all groups. However, the use of electrostimulation is typical in China and was used in the control group to ensure blinding. Some types of electrostimulation have been reported to be beneficial for short-term relief of pain, [27] [28] [29] potentially leading to stronger pain-control mechanisms than intended in the control group. This might be explained by the endorphin hypothesis (release of endogenous opioids by electrostimulation). Melzack's gate control theory and diffuse noxious inhibitory control might explain the stronger effect on pain inhibitory mechanisms caused by more intense local pain stimulus induced by electrostimulation. [30] [31] [32] [33] This might explain why we found no significant differences between the acupuncture and sham acupuncture groups directly following the treatment period (weeks 5-8) but we did find differences later (weeks [13] [14] [15] [16] . Based on results from previous trials involving patients with migraines, 8, 11, 12, 34 we speculate that the effect would have increased even further with a longer follow-up period. The higher frequency and number of treatments used in our trial (compared with other Western studies 11, 12 ) did not result in clinically meaningful effects at the end of the intervention, and the results of our study could be difficult to generalize to Western populations.
A recent Cochrane review of acupuncture for migraine prophylaxis 6 concluded that no evidence exists for an effect from "true" acupuncture compared with sham interventions, but there was an effect compared with usual care. However, we found that the outcomes following acupuncture were significantly better than with sham acupuncture during weeks 13-16, but the effect was clinically minor. Of the two largest acupuncture trials included in the Cochrane review, 10,11 the patients included in our trial and our results are more comparable with the trial by Diener and colleagues, 11 in which the patients had a similar mean number of migraine attacks and days with migraine. How- ever, our results had less variance. Diener and colleagues also reported a significant, but clinically minor, difference between acupuncture and sham acupuncture at follow-up (26 wks) but not at the end of treatment (13 wks). The fact that only one-third of patients in our trial used acute pain medication at baseline is in line with the results from a cross-sectional study in China, which showed that only half of the outpatient of a neurologic department used analgesics for the treatment of migraine.
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Limitations
The limitations of our trial include a short follow-up period and self-reported outcome measures. In addition, the physicians were not blinded as to the patients' treatment assignment. Thus, we are unsure of how much of the observed changes represent the biological effects of acupuncture and how much is due to nonspecific effects. However, patients were unaware of their treatment group, and all had been informed that they would receive "real" acupuncture in order to reduce the chance of unblinding.
Patients in the Shaoyang-specific acupuncture group reported the highest number of days with a migraine at baseline and the greatest effect after treatment, but these analyses were based on analysis of covariance models with baselineadjustments, which accounts, to some extent, for the problem of regression to the mean.
Although there is a current trend toward comparative effectiveness research, [36] [37] [38] our trial had a strong focus on efficacy.
The small number of acupuncture points included in our trial might be another limitation; however, the points that we chose are commonly used and have been shown to be beneficial for the treatment of acute migraine attacks. 23 
Conclusion
Acupuncture appeared to have a clinically minor prophylactic effect for migraine. However, the nonspecific effects of acupuncture may play a relevant role, and future research should provide more insight into the nature of these effects.
